<DOC>
	<DOCNO>NCT01511146</DOCNO>
	<brief_summary>The purpose study see treatment intrahepatic chemotherapy good option patient liver metastasis . If patient colorectal cancer never get chemotherapy investigator use oxaliplatin together capecitabine . If patient K-RAS wild type investigator add cetuximab . In patient receive oxaliplatin patient cancer investigator use mitomycin gemcitabine together capecitabine .</brief_summary>
	<brief_title>Intrahepatic Chemotherapy Patients With Non-resectable Liver Metastases From Solid Tumor</brief_title>
	<detailed_description>Two regiment use : N.B . The two regiment report separately 1 . Mitomycin + Gemcitabine intrahepatic together Capecitabine . This treatment offer patient solid tumor standard treatment use . The patient allow extrahepatic disease . The purpose treatment prolonged life . 2 . FOLFOX oxaliplatin give intrahepatic second time . The treatment patient colorectal cancer cure possible resection straight ahead possible . The patient allow colorectal cancer situ operation latter . If patient KRAS Wild-type , cetuximab add .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>liver metastasis solid tumor poor performance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>oxaliplatin</keyword>
	<keyword>mitomycin</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>intrahepatic</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>response liver metastasis</keyword>
	<keyword>downsize operation</keyword>
</DOC>